Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin and Pralatrexate in Recurrent Platinum-Sensitive Ovarian Cancer
NCT01188876Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Aug 2010
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pralatrexate in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Massachusetts General Hospital. Started Aug 2010; status: completed.
02
Drugs
pralatrexate
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT01188876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01188876.